Skip to main navigation Skip to search Skip to main content

Confidence Interval Estimation for Sensitivity to the Early Diseased Stage Based on Empirical Likelihood

  • SUNY Buffalo

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Many disease processes can be divided into three stages: the non-diseased stage: the early diseased stage, and the fully diseased stage. To assess the accuracy of diagnostic tests for such diseases, various summary indexes have been proposed, such as volume under the surface (VUS), partial volume under the surface (PVUS), and the sensitivity to the early diseased stage given specificity and the sensitivity to the fully diseased stage (P2). This paper focuses on confidence interval estimation for P2 based on empirical likelihood. Simulation studies are carried out to assess the performance of the new methods compared to the existing parametric and nonparametric ones. A real dataset from Alzheimers Disease Neuroimaging Initiative (ADNI) is analyzed.

Original languageEnglish
Pages (from-to)1215-1233
Number of pages19
JournalJournal of Biopharmaceutical Statistics
Volume25
Issue number6
DOIs
StatePublished - Nov 2 2015

Keywords

  • Diagnostic tests
  • Empirical likelihood
  • The sensitivity to the early diseased stage

Fingerprint

Dive into the research topics of 'Confidence Interval Estimation for Sensitivity to the Early Diseased Stage Based on Empirical Likelihood'. Together they form a unique fingerprint.

Cite this